SEHK:2031

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Ausupreme International Holdings

Executive Summary

Ausupreme International Holdings Limited, an investment holding company, engages in the retail and wholesale of health and personal care products in Hong Kong, Mainland China, Singapore, and Macau.


Snowflake Analysis

Flawless balance sheet and good value.

Share Price & News

How has Ausupreme International Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 2031 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

2031

7.6%

HK Retail Distributors

9.1%

HK Market


1 Year Return

-42.3%

2031

-11.1%

HK Retail Distributors

0.9%

HK Market

Return vs Industry: 2031 underperformed the Hong Kong Retail Distributors industry which returned -9% over the past year.

Return vs Market: 2031 underperformed the Hong Kong Market which returned -6% over the past year.


Shareholder returns

2031IndustryMarket
7 Day0%7.6%9.1%
30 Day0%7.7%8.2%
90 Day-6.3%5.1%13.8%
1 Year-38.7%-42.3%-8.7%-11.1%4.6%0.9%
3 Year-17.2%-24.1%-36.2%-40.4%13.1%1.4%
5 Yearn/a-53.1%-57.0%10.8%-7.1%

Price Volatility Vs. Market

How volatile is Ausupreme International Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Ausupreme International Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 2031 (HK$0.3) is trading below our estimate of fair value (HK$1.19)

Significantly Below Fair Value: 2031 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 2031 is good value based on its PE Ratio (8.1x) compared to the Retail Distributors industry average (9.3x).

PE vs Market: 2031 is good value based on its PE Ratio (8.1x) compared to the Hong Kong market (9.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 2031's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 2031 is overvalued based on its PB Ratio (1.3x) compared to the HK Retail Distributors industry average (0.6x).


Next Steps

Future Growth

How is Ausupreme International Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

2.8%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ausupreme International Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Ausupreme International Holdings performed over the past 5 years?

28.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 2031 has high quality earnings.

Growing Profit Margin: 2031's current net profit margins (10.2%) are higher than last year (8.8%).


Past Earnings Growth Analysis

Earnings Trend: 2031's earnings have grown significantly by 28.1% per year over the past 5 years.

Accelerating Growth: 2031's earnings growth over the past year (16.9%) is below its 5-year average (28.1% per year).

Earnings vs Industry: 2031 earnings growth over the past year (16.9%) exceeded the Retail Distributors industry -0.3%.


Return on Equity

High ROE: 2031's Return on Equity (16.1%) is considered low.


Next Steps

Financial Health

How is Ausupreme International Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 2031's short term assets (HK$180.1M) exceed its short term liabilities (HK$53.2M).

Long Term Liabilities: 2031's short term assets (HK$180.1M) exceed its long term liabilities (HK$13.6M).


Debt to Equity History and Analysis

Debt Level: 2031 is debt free.

Reducing Debt: 2031 has no debt compared to 5 years ago when its debt to equity ratio was 23.9%.

Debt Coverage: 2031 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 2031 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Ausupreme International Holdings's current dividend yield, its reliability and sustainability?

10.00%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 2031's dividend (10%) is higher than the bottom 25% of dividend payers in the Hong Kong market (2.46%).

High Dividend: 2031's dividend (10%) is in the top 25% of dividend payers in the Hong Kong market (7.1%)


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, 2031 has been paying a dividend for less than 10 years.

Growing Dividend: 2031's dividend payments have increased, but the company has only paid a dividend for 2 years.


Current Payout to Shareholders

Dividend Coverage: At its current payout ratio (80.7%), 2031's payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.5yrs

Average board tenure


CEO

Chi Fai Choy (44yo)

no data

Tenure

HK$1,520,000

Compensation

Mr. Chi Fai Choy serves as the Managing Director of Ausupreme International Holdings Limited and has been its Executive Director since April 17, 2015. Mr. Choy is responsible for the overall direction and  ...


CEO Compensation Analysis

Compensation vs Market: Chi Fai's total compensation ($USD0.00) is below average for companies of similar size in the Hong Kong market ($USD224.77K).

Compensation vs Earnings: Chi Fai's compensation has increased by more than 20% in the past year.


Board Members

NamePositionTenureCompensationOwnership
Chi Fai Choy
MD & Chairmanno dataHK$1.52mno data
Chun Kit Au
Operations Director & Executive Director5.08yrsHK$876.00kno data
Ka Man Ho
MD & Executive Director5.17yrsHK$1.42mno data
Chun Kit Ho
Business Development Director and Executive Director5.08yrsHK$1.07mno data
Ming Kin Ko
Independent Non-Executive Director3.92yrsHK$180.00kno data
Ting Kwong Luk
Independent Non-Executive Director3.92yrsHK$180.00kno data
Cho Yee Wan
Independent Non-Executive Director3.92yrsHK$180.00kno data

4.5yrs

Average Tenure

49yo

Average Age

Experienced Board: 2031's board of directors are considered experienced (4.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ausupreme International Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ausupreme International Holdings Limited
  • Ticker: 2031
  • Exchange: SEHK
  • Founded: 2001
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: HK$228.600m
  • Shares outstanding: 762.00m
  • Website: https://www.ausupreme.com

Number of Employees


Location

  • Ausupreme International Holdings Limited
  • EGL Tower
  • 28th Floor
  • Kwun Tong
  • Kowloon
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
2031SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDSep 2016

Biography

Ausupreme International Holdings Limited, an investment holding company, engages in the retail and wholesale of health and personal care products in Hong Kong, Mainland China, Singapore, and Macau. The company offers beauty and nutrition products for whitening, beauty, and antioxidant applications; brain and eye development products; products for enhancing strength and immunity; skeletal and men health products to strengthen muscles and bones, as well as promotes vitality; and health and nutrition products that facilitates body metabolism. It also provides slimming and body health products, which helps in slimming and softening blood vessels; vitamin products to support metabolism and energy generation; and children's supplements to enhance IQ and emotional control. In addition, the company offers body care products for moisturizing, nourishing, and anti-aging applications; and honey to protect the lungs and enhance discomfort of throat. Further, it is involved in holding trademarks; and property investment activities. The company markets its products primarily under the Organic Nature, Top Life, Superbee, and Ausupreme brand names. As of March 31, 2019, the company operated 13 specialty stores and 83 consignment counters. It also sells its products through other sales channels, including distributors, trade fairs, and exhibitions, as well as e-commerce channels. The company was founded in 2001 and is headquartered in Kwun Tong, Hong Kong. Ausupreme International Holdings Limited is a subsidiary of Beatitudes International Ltd. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/06/12 13:59
End of Day Share Price2020/03/16 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.